Add like
Add dislike
Add to saved papers

Combined coagulation-electrocoagulation process using biocoagulant from the Opuntia ficus-indica for treatment of cheese whey wastewater.

This work reports a combined coagulation-electrocoagulation process using a biocoagulant from the Opuntia ficus-indica for treatment of cheese whey wastewater. The process parameters as pH, biocoagulant dosage, and current density were evaluated from the chemometric tools. A Box-Behnken design was used, having as responses the removal percentages of turbidity and chemical oxygen demand (COD). The results showed that for the studied variable ranges, linear models were obtained and the pH was parameter more significant for treatment proposed. The pH showed synergic effect with the investigated parameters, while the biocoagulant dosage and density current showed antagonistic effects. The desirability function was used to optimization of process, and suggested values were pH 10.0, biocoagulant dosage of 4.4 g L-1 , and current density of 31.5 mA cm-2 , which showed removals of turbidity and COD of 98.9 and 83.8%, respectively.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app